Magnesium Depletion Score is Associated with Long-Term Mortality in Chronic Kidney Diseases: A Prospective Population-Based Cohort Study

被引:20
作者
Yin, Saifu [1 ,3 ]
Zhou, Zhaoxia [1 ,2 ]
Lin, Tao [1 ,3 ]
Wang, Xianding [1 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Urol, Inst Urol, Guoxue Alley 37, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, West China Sch Nursing, Ward Nephrol & Urol, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Organ Transplantat Ctr, Chengdu 610041, Sichuan, Peoples R China
关键词
Chronic kidney diseases; Magnesium deficiency; Mortality; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; SUPPLEMENTATION; COMPLICATIONS; UPDATE; RISK;
D O I
10.1007/s40620-022-01489-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Magnesium deficiency is common in patients with chronic kidney diseases (CKD) due to restricted magnesium intake and impaired magnesium reabsorption. Based on pathophysiological risk factors influencing kidney magnesium reabsorption, a magnesium depletion score (MDS) was developed. Using MDS as a novel indicator for assessing body magnesium status, we hypothesized that it was associated with clinical prognosis. Methods We conducted a prospective population-based cohort study using data from the National Health and Nutrition Examination Survey 1999-2014 to explore the impact of MDS on the clinical outcomes of CKD patients. Propensity score-matched analyses were conducted to increase comparability. The primary outcome was all-cause mortality, and the secondary outcomes were cardiovascular-cause and cancer-cause mortality. Results After propensity score matching, 3294 CKD patients were divided into 2 groups: MDS <= 2 (N = 1647), and MDS >2 (N = 1647). During a median follow-up of 75 months, Kaplan-Meier analyses showed that MDS > 2 was associated with worse 5- and 10-year overall survival (78.5% vs 73.4%; 53.1% vs 43.1%, P < 0.001). After adjusting for confounding variables, MDS was found to be an independent risk factor for all-cause mortality (HR:1.34, 95% CI 1.20-1.50, P < 0.001). MDS > 2 was also associated with higher cardiovascular-cause mortality (16.2% VS 11.6%, P= 0.005). Multivariate competing risk analysis revealed that MDS > 2 was an independent risk factor (HR: 1.33, 95% CI 1.06-1.66, P = 0.012). Subgroup analyses reported that MDS > 2 increased all-cause mortality and cardiovascular-cause mortality only in patients with inadequate magnesium intake (P < 0.001, P < 0.001) but not in those with adequate intake (P = 0.068, P = 0.920). Conclusions A magnesium depletion score > 2 was independently associated with higher long-term cardiovascular-cause and all-cause mortality in CKD patients. [GRAPHICS] .
引用
收藏
页码:755 / 765
页数:11
相关论文
共 28 条
[1]   Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy [J].
Ahluwalia, Namanjeet ;
Dwyer, Johanna ;
Terry, Ana ;
Moshfegh, Alanna ;
Johnson, Clifford .
ADVANCES IN NUTRITION, 2016, 7 (01) :121-134
[2]  
[Anonymous], 1997, DIETARY REFERENCE IN
[3]   Update on the assessment of magnesium status [J].
Arnaud, Maurice J. .
BRITISH JOURNAL OF NUTRITION, 2008, 99 :S24-S36
[4]   The impact of insulin resistance on the kidney and vasculature [J].
Artunc, Ferruh ;
Schleicher, Erwin ;
Weigert, Cora ;
Fritsche, Andreas ;
Stefan, Norbert ;
Haering, Hans-Ulrich .
NATURE REVIEWS NEPHROLOGY, 2016, 12 (12) :721-737
[5]   Serum magnesium, mortality and disease progression in chronic kidney disease [J].
Azem, Rami ;
Daou, Remy ;
Bassil, Elias ;
Anvari, Eva Maria ;
Taliercio, Jonathan J. ;
Arrigain, Susana ;
Schold, Jesse D. ;
Vachharajani, Tushar ;
Nally, Joseph ;
Khoul, Georges N. Na .
BMC NEPHROLOGY, 2020, 21 (01)
[6]   Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action [J].
Bello, Aminu K. ;
Alrukhaimi, Mona ;
Ashuntantang, Gloria E. ;
Basnet, Shakti ;
Rotter, Ricardo C. ;
Douthat, Walter G. ;
Kazancioglu, Rumeyza ;
Koettgen, Anna ;
Nangaku, Masaomi ;
Powe, Neil R. ;
White, Sarah L. ;
Wheeler, David C. ;
Moe, Orson .
KIDNEY INTERNATIONAL SUPPLEMENTS, 2017, 7 (02) :122-129
[7]   Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].
Bikbov, Boris ;
Purcell, Carrie ;
Levey, Andrew S. ;
Smith, Mari ;
Abdoli, Amir ;
Abebe, Molla ;
Adebayo, Oladimeji M. ;
Afarideh, Mohsen ;
Agarwal, Sanjay Kumar ;
Agudelo-Botero, Marcela ;
Ahmadian, Elham ;
Al-Aly, Ziyad ;
Alipour, Vahid ;
Almasi-Hashiani, Amir ;
Al-Raddadi, Rajaa M. ;
Alvis-Guzman, Nelson ;
Amini, Saeed ;
Andrei, Tudorel ;
Andrei, Catalina Liliana ;
Andualem, Zewudu ;
Anjomshoa, Mina ;
Arabloo, Jalal ;
Ashagre, Alebachew Fasil ;
Asmelash, Daniel ;
Ataro, Zerihun ;
Atout, Maha Moh'd Wahbi ;
Ayanore, Martin Amogre ;
Badawi, Alaa ;
Bakhtiari, Ahad ;
Ballew, Shoshana H. ;
Balouchi, Abbas ;
Banach, Maciej ;
Barquera, Simon ;
Basu, Sanjay ;
Bayih, Mulat Tirfie ;
Bedi, Neeraj ;
Bello, Aminu K. ;
Bensenor, Isabela M. ;
Bijani, Ali ;
Boloor, Archith ;
Borzi, Antonio M. ;
Camera, Luis Alberto ;
Carrero, Juan J. ;
Carvalho, Felix ;
Castro, Franz ;
Catala-Lopez, Ferran ;
Chang, Alex R. ;
Chin, Ken Lee ;
Chung, Sheng-Chia ;
Cirillo, Massimo .
LANCET, 2020, 395 (10225) :709-733
[8]   Renal Control of Calcium, Phosphate, and Magnesium Homeostasis [J].
Blaine, Judith ;
Chonchol, Michel ;
Levi, Moshe .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (07) :1257-1272
[9]   Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial [J].
Bressendorff, Iain ;
Hansen, Ditte ;
Schou, Morten ;
Silver, Burton ;
Pasch, Andreas ;
Bouchelouche, Pierre ;
Pedersen, Lise ;
Rasmussen, Lars Melholt ;
Brandi, Lisbet .
KIDNEY INTERNATIONAL REPORTS, 2017, 2 (03) :380-389
[10]   Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population [J].
Covic, Adrian ;
Vervloet, Marc ;
Massy, Ziad A. ;
Torres, Pablo Urena ;
Goldsmith, David ;
Brandenburg, Vincent ;
Mazzaferro, Sandro ;
Evenepoel, Pieter ;
Bover, Jordi ;
Apetrii, Mugurel ;
Cozzolino, Mario .
LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (04) :319-331